title: Medication treatment in first-admission patients with psychotic affective disorders: preliminary findings on research-facility diagnostic agreement and rehospitalization.
abstract: The discharge medications of 101 Suffolk County subjects with facility and/or research diagnoses of affective disorder were ascertained. Rehospitalization was recorded for a 6-month follow-up period. Twenty-three of 31 patients (74.2%) with a facility diagnosis of depressive disorder were prescribed antidepressants, and 21 of 36 patients with a facility diagnosis of bipolar disorder (58.3%) were prescribed lithium. When research and facility diagnoses concurred, 84.2% of depressed patients were prescribed antidepressants, and 66.7% of bipolars were given lithium. The percentages were lower when the two diagnoses were discrepant. The results for diagnostic congruence were independent of demographic variables, length of stay, and premorbid functioning. Patients prescribed diagnosis-specific medications had a lower rate of rehospitalization (7.3%) than those not prescribed such medications (22.2%). The findings suggest that such medications are prescribed in the more unambiguous cases of affective disorders and are important (with or without antipsychotic treatment) in preventing rehospitalization.
authors.affiliation: State University of New York at Stony Brook, USA.
authors.forename: S
authors.initials: S
authors.lastname: Fennig
authors.forename: T J
authors.initials: TJ
authors.lastname: Craig
authors.forename: M
authors.initials: M
authors.lastname: Tanenberg-Karant
authors.forename: L
authors.initials: L
authors.lastname: Jandorf
authors.forename: B
authors.initials: B
authors.lastname: Rosen
authors.forename: E J
authors.initials: EJ
authors.lastname: Bromet
mesh_terms: D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy* / Q000534:rehabilitation*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy* / Q000534:rehabilitation*; D005500:Follow-Up Studies; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006801:Humans; D008875:Middle Aged; D010343:Patient Admission; D011618:Psychotic Disorders / Q000150:complications; D014149:Tranquilizing Agents / Q000627:therapeutic use*
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D014149:Tranquilizing Agents